Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 6016 to 6030 of 7707 results

  1. Oxygen therapy for OSAHS: What is the clinical and cost effectiveness of nocturnal oxygen compared with placebo in people with OSAHS who are unable to tolerate CPAP?

    Recommendation ID NG202/9 Question Oxygen therapy for OSAHS: What is the clinical and cost effectiveness of nocturnal oxygen compared with

    Research recommendation
    Published
    30 September 2021

  2. Direct oral anticoagulants for people with lower limb immobilisation:- What is the clinical and cost effectiveness of direct oral anticoagulants for preventing VTE in people with lower limb immobilisation?

    Recommendation ID NG89/3 Question Direct oral anticoagulants for people with lower limb immobilisation:- What is the clinical and cost

    Research recommendation
    Published
    15 November 2018

  3. Optimising nutritional status in children with cerebral palsy:- What is the clinical and cost effectiveness of early interventions for optimising protein, energy and micronutrient nutritional status in children with cerebral palsy?

    Recommendation ID NG62/1 Question Optimising nutritional status in children with cerebral palsy:- What is the clinical and cost effectiveness

    Research recommendation
    Published
    17 February 2017

  4. Early supported discharge in care home patients: What is the clinical and cost effectiveness of early supported discharge on mortality, quality of life and functional status in people with hip fracture who are admitted from a care home?

    Recommendation ID CG124/05 Question Early supported discharge in care home patients: What is the clinical and cost effectiveness of early

    Research recommendation
    Published
    3 February 2023

  5. Transcranial doppler monitoring: What is the clinical and cost effectiveness of routine transcranial doppler monitoring to guide clinical management of aneurysmal subarachnoid haemorrhage?

    Recommendation ID NG228/08 Question Transcranial doppler monitoring: What is the clinical and cost effectiveness of routine transcranial

    Research recommendation
    Published
    12 December 2022

  6. Novel endovascular interventions: What is the clinical and cost effectiveness of novel endovascular techniques and devices such as coated coils, endoluminal flow diverters and intrasaccular devices to treat aneurysmal subarachnoid haemorrhage?

    Recommendation ID NG228/04 Question Novel endovascular interventions: What is the clinical and cost effectiveness of novel endovascular

    Research recommendation
    Published
    12 December 2022

  7. Identification of breech presentation: What is the clinical and cost effectiveness of routine ultrasound from 36+0 weeks compared with selective ultrasound in identifying breech presentation?

    Recommendation ID NG201/4 Question Identification of breech presentation: What is the clinical and cost effectiveness of routine ultrasound

    Research recommendation
    Published
    30 September 2021

  8. Selective dorsal rhizotomy treatment to reduce spasticity:- What is the clinical and cost effectiveness of selective dorsal rhizotomy compared with intrathecal baclofen to reduce spasticity in adults with cerebral palsy?

    Recommendation ID NG119/2 Question Selective dorsal rhizotomy treatment to reduce spasticity:- What is the clinical and cost effectiveness

    Research recommendation
    Published
    8 March 2019

  9. Follow-up strategies: What is the clinical and cost effectiveness of patient-initiated follow-up compared with routine follow-up for people with osteoarthritis?

    Recommendation ID NG226/04 Question Follow-up strategies: What is the clinical and cost effectiveness of patient-initiated follow-up compared

    Research recommendation
    Published
    7 November 2022

  10. Self-monitoring management strategies: What is the clinical and cost effectiveness of self-monitoring strategies and techniques in guiding energy management?

    Recommendation ID NG206/04 Question Self-monitoring management strategies: What is the clinical and cost effectiveness of self-monitoring

    Research recommendation
    Published
    8 November 2021

  11. Sequencing and further line treatment:- What is the clinical and cost effectiveness of sequencing and further line treatment in PTSD?

    Recommendation ID NG116/2 Question Sequencing and further line treatment:- What is the clinical and cost effectiveness of sequencing and

    Research recommendation
    Published
    13 February 2019

  12. Pharmacological management for adults with heart valve disease: What is the clinical and cost effectiveness of pharmacological management of heart failure for adults with heart failure and severe aortic stenosis, severe aortic regurgitation or severe mitral regurgitation?

    Recommendation ID NG208/18 Question Pharmacological management for adults with heart valve disease: What is the clinical and cost effectiveness

    Research recommendation
    Published
    16 December 2021

  13. Digital health technologies: What is the clinical and cost effectiveness of digital health technologies in people with epilepsy?

    Recommendation ID NG217/07 Question Digital health technologies: What is the clinical and cost effectiveness of digital health technologies

    Research recommendation
    Published
    11 May 2022

  14. Is response to pharmacological treatment predicted more reliably by underlying aetiology or by symptom characteristics?

    Recommendation ID CG173/2 Question Is response to pharmacological treatment predicted more reliably by underlying aetiology or by symptom

    Research recommendation
    Published
    26 October 2020

  15. NICE may update this guidance after 3 years or sooner if important new information becomes available, including evidence on: the epidemiology of CJD, including data on the prevalence of CJD and its infectivity in the UK population the transmission of CJD by surgical instruments, including cases of CJD in which surgery is a possible route of transmission the cost effectiveness of single-use instruments for use in interventional procedures on high-risk tissues commercially available decontmination methods that are safe and cost effective against prions the systems for, and cost effectiveness of, maintaining set integrity and traceability of instruments.

    Recommendation ID IPG666/1 Question NICE may update this guidance after 3 years or sooner if important new information becomes available

    Research recommendation
    Published
    10 February 2020